Compensatory hyperinsulinemia and increased insulin production, in mice with transgenically enhanced galectin 3 expression, is enough to sustain relatively normal fasting glycemia compared to the control group on HFD but is insufficient after glucose load (Figure 1). The gene discussed is INS; the disease is hyperinsulinism.